Format

Send to

Choose Destination
PLoS One. 2014 May 12;9(5):e96915. doi: 10.1371/journal.pone.0096915. eCollection 2014.

Cerebral cortex hyperthyroidism of newborn mct8-deficient mice transiently suppressed by lat2 inactivation.

Author information

1
Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas (CSIC) and Universidad Autónoma de Madrid (UAM), Madrid, Spain.
2
Laboratorio de Genètica Molecular, IDIBELL, Barcelona, Spain; Center for Biomedical Research on Rare Diseases (CIBERER) Unit 730, Barcelona, Spain.
3
Laboratorio de Genètica Molecular, IDIBELL, Barcelona, Spain; Center for Biomedical Research on Rare Diseases (CIBERER) Unit 730, Barcelona, Spain; Sección de Genética, Departamento de Ciencias Fisiológicas II, Facultad de Medicina, Universidad de Barcelona, Barcelona, Spain.
4
Institute for Research in Biomedicine (IRB), Barcelona, Spain; CIBERER Unit 731, Barcelona, Spain.
5
Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
6
Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas (CSIC) and Universidad Autónoma de Madrid (UAM), Madrid, Spain; CIBERER Unit 708, Madrid, Spain.

Abstract

Thyroid hormone entry into cells is facilitated by transmembrane transporters. Mutations of the specific thyroid hormone transporter, MCT8 (Monocarboxylate Transporter 8, SLC16A2) cause an X-linked syndrome of profound neurological impairment and altered thyroid function known as the Allan-Herndon-Dudley syndrome. MCT8 deficiency presumably results in failure of thyroid hormone to reach the neural target cells in adequate amounts to sustain normal brain development. However during the perinatal period the absence of Mct8 in mice induces a state of cerebral cortex hyperthyroidism, indicating increased brain access and/or retention of thyroid hormone. The contribution of other transporters to thyroid hormone metabolism and action, especially in the context of MCT8 deficiency is not clear. We have analyzed the role of the heterodimeric aminoacid transporter Lat2 (Slc7a8), in the presence or absence of Mct8, on thyroid hormone concentrations and on expression of thyroid hormone-dependent cerebral cortex genes. To this end we generated Lat2-/-, and Mct8-/yLat2-/- mice, to compare with wild type and Mct8-/y mice during postnatal development. As described previously the single Mct8 KO neonates had a transient increase of 3,5,3'-triiodothyronine concentration and expression of thyroid hormone target genes in the cerebral cortex. Strikingly the absence of Lat2 in the double Mct8Lat2 KO prevented the effect of Mct8 inactivation in newborns. The Lat2 effect was not observed from postnatal day 5 onwards. On postnatal day 21 the Mct8 KO displayed the typical pattern of thyroid hormone concentrations in plasma, decreased cortex 3,5,3'-triiodothyronine concentration and Hr expression, and concomitant Lat2 inactivation produced little to no modifications. As Lat2 is expressed in neurons and in the choroid plexus, the results support a role for Lat2 in the supply of thyroid hormone to the cerebral cortex during early postnatal development.

PMID:
24819605
PMCID:
PMC4018440
DOI:
10.1371/journal.pone.0096915
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center